The effect of flubendazole on temozolomide treatment in glioblastoma cell

被引：0
|
作者：
Dvorakova, K. [1 ]
Vitovcova, B. [1 ]
Skarka, A. [2 ]
Caltova, K. [3 ]
Rudolf, E. [3 ]
机构：
[1] Charles Univ Prague, Fac Med Hradec Kralove, Dept Med Biol & Genet, Hradec Kralove, Czech Republic
[2] Univ Hradec Kralove, Fac Sci, Hradec Kralove, Czech Republic
[3] Charles Univ Prague, Fac Med Hradec Kralove, Hradec Kralove, Czech Republic
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 08期
关键词：
D O I：
10.1016/j.annonc.2022.09.090
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1410 / S1411
页数：2
相关论文
共 50 条
  • [31] Temozolomide treatment combined with AZD3463 shows synergistic effect in glioblastoma cells
    Bagca, Bakiye Goker
    Ozates, Neslihan Pinar
    Asik, Aycan
    Caglar, Hasan Onur
    Gunduz, Cumhur
    Avci, Cigir Biray
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 533 (04) : 1497 - 1504
  • [32] Juglone in Combination with Temozolomide Shows a Promising Epigenetic Therapeutic Effect on the Glioblastoma Cell Line
    Barciszewska, Anna-Maria
    Belter, Agnieszka
    Gawronska, Iwona
    Giel-Pietraszuk, Malgorzata
    Naskret-Barciszewska, Miroslawa Z.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [33] Combined Thalidomide and Temozolomide Treatment in Patients with Glioblastoma Multiforme
    Fabian Baumann
    Miroslava Bjeljac
    Spyros S. Kollias
    Brigitta G. Baumert
    Sebastian Brandner
    Valentin Rousson
    Yasuhiro Yonekawa
    René L. Bernays
    Journal of Neuro-Oncology, 2004, 67 : 191 - 200
  • [34] Combined thalidomide and temozolomide treatment in patients with glioblastoma multiforme
    Baumann, F
    Bjeljac, M
    Kollias, SS
    Baumert, BG
    Brandner, S
    Rousson, V
    Yonekawa, Y
    Bernays, RL
    JOURNAL OF NEURO-ONCOLOGY, 2004, 67 (1-2) : 191 - 200
  • [35] Identification of senolytic agents for sequential treatment of glioblastoma with temozolomide
    Beltzig, Lea
    Stratenwerth, Bjoern
    Christmann, Markus
    Kaina, Bernd
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 45 - 45
  • [36] Sensitizer drugs for the treatment of temozolomide-resistant glioblastoma
    Baritchii, Adriana
    Jurj, Anca
    Soritau, Olga
    Tomuleasa, Ciprian
    Raduly, Layos
    Zanoaga, Oana
    Cernea, Dana
    Braicu, Cornelia
    Neagoe, Ioana
    Florian, Ioan Stefan
    JOURNAL OF BUON, 2016, 21 (01): : 199 - 207
  • [37] Obstacles to Glioblastoma Treatment Two Decades after Temozolomide
    Cruz, Joao Victor Roza
    Batista, Carolina
    Afonso, Bernardo de Holanda
    Alexandre-Moreira, Magna Suzana
    Dubois, Luiz Gustavo
    Pontes, Bruno
    Moura Neto, Vivaldo
    Mendes, Fabio de Almeida
    CANCERS, 2022, 14 (13)
  • [38] Temozolomide and Other Potential Agents for the Treatment of Glioblastoma Multiforme
    Nagasawa, Daniel T.
    Chow, Frances
    Yew, Andrew
    Kim, Won
    Cremer, Nicole
    Yang, Isaac
    NEUROSURGERY CLINICS OF NORTH AMERICA, 2012, 23 (02) : 307 - +
  • [39] REPURPOSING ITRACONAZOLE AND PYRIMETHAMINE WITH TEMOZOLOMIDE AS A COMBINATORIAL TREATMENT FOR GLIOBLASTOMA
    Lootens, T.
    Vandersteene, J.
    Pinson, H.
    Boterberg, T.
    Vermeirssen, V.
    De Wever, O.
    De Smet, F.
    Raedt, R.
    NEURO-ONCOLOGY, 2024, 26 : V135 - V135
  • [40] Polymer zwitterion-temozolomide conjugates for glioblastoma treatment
    Ward, Sarah
    Skinner, Matthew
    Saha, Banishree
    Emrick, Todd
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
12345